Oct '24 • General discussion
$HIMs down -7%
Novo Nordisk asks the FDA to ban compounding pharmacies from making copies of Ozempic and Wegovy.
$HIMS down ~7% following this.
Seems like a buying opportunity to me but will leave it for a minute to see how this plays out over the next week or so before earnings 4th Nov.
2
0 comments
$HIMs down -7%
skool.com/patience-pays-portfolio-1157
Join our growth investing community for top stock picks, market news, and insights. Discover high-growth opportunities and trends shaping the future!
Leaderboard (30-day)
1
+1
2
+1
Powered by